Cutaneous Candidiasis
Conditions
Interventions
This is a prospective, interventional, double-blind, randomized clinical study. A total of 70 patients who meet the eligibility criteria will be allocated into two intervention groups - group 1: exper
Sponsors
Centro de Ciências Médicas da Universidade Federal de Pernambuco
Hospital da Restauração de Pernambuco Governador Paulo Guerra
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients hospitalized in the Intensive Care Units of the Hospital da Restauração who have skin colonization with Candida auris confirmed by the hospital's clinical analysis laboratory, aged 18 years or older, without limitation of gender and race and who have signed the Term of Free and Informed Consent - TCLE
Exclusion criteria
Exclusion criteria: Patients with a previous diagnosis of superficial or invasive mycosis and who are using antifungal therapies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A new antiseptic derived from pyridyl-thiazolidinone is expected to be safe and effective for skin decolonization by Candida auris, verified by means of the fungal isolation method and microbial count, based on the verification of a variation in the growth rate of colonies pre and post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to help public policies in the State of Pernambuco aimed at controlling and preventing outbreaks of fungal infections through the identification of clinical strains of Candida auris using a chromogenic and proteomic approach and mapping of the main risk factors involved in cases of colonization. | — |
Countries
Brazil
Contacts
Public ContactReginaldo de Lima Neto
Universidade Federal de Pernambuco
Outcome results
None listed